Published in Ann Surg on November 01, 2002
Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery. Obesity (Silver Spring) (2013) 2.22
The relationship between hospital volume and outcome in bariatric surgery at academic medical centers. Ann Surg (2004) 2.07
Laparoscopic Roux-en-Y gastric bypass, but not rebanding, should be proposed as rescue procedure for patients with failed laparoscopic gastric banding. Ann Surg (2003) 1.67
Multivariate analysis of risk factors for death following gastric bypass for treatment of morbid obesity. Ann Surg (2004) 1.58
The incidence of bariatric surgery has plateaued in the U.S. Am J Surg (2010) 1.49
Relationship of body mass index with demographic and clinical characteristics in the Longitudinal Assessment of Bariatric Surgery (LABS). Surg Obes Relat Dis (2008) 1.41
Factors affecting morbidity and mortality of Roux-en-Y gastric bypass for clinically severe obesity: an analysis of 1,000 consecutive open cases by a single surgeon. J Gastrointest Surg (2007) 1.39
Experience with over 3,000 open and laparoscopic bariatric procedures: multivariate analysis of factors related to leak and resultant mortality. Surg Endosc (2003) 1.32
Capacity for physical activity predicts weight loss after Roux-en-Y gastric bypass. Obesity (Silver Spring) (2008) 1.17
Effects of bariatric surgery in older patients. Ann Surg (2004) 1.15
Impact of bariatric surgery on life expectancy in severely obese patients with diabetes: a decision analysis. Ann Surg (2015) 1.08
Predictors of patient selection in bariatric surgery. Ann Surg (2007) 1.06
Risk factors associated with mortality after Roux-en-Y gastric bypass surgery. Ann Surg (2014) 0.94
Thyroid surgery in octogenarians is associated with higher complication rates. Surgery (2009) 0.92
Preoperative factors predictive of complicated postoperative management after Roux-en-Y gastric bypass for morbid obesity. Surg Endosc (2003) 0.92
Advanced age and sex as predictors of adverse outcomes following gastric bypass surgery. JSLS (2005) 0.91
Decision modeling to estimate the impact of gastric bypass surgery on life expectancy for the treatment of morbid obesity. Arch Surg (2010) 0.90
Laparoscopic sleeve gastrectomy: an alternative for recurrent paraesophageal hernias in obese patients. JSLS (2006) 0.88
Bariatric surgery in old age: a comparative study of laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy in an Asia centre of excellence. J Biomed Res (2015) 0.87
A call to arms: obese men with more severe comorbid disease and underutilization of bariatric operations. Surg Endosc (2013) 0.87
Sleeve gastrectomy as a stand-alone bariatric operation for severe, morbid, and super obesity. JSLS (2013) 0.86
The duodenal switch operation for the treatment of morbid obesity. Ann Surg (2003) 0.85
Prevention of venous thromboembolism in patients undergoing bariatric surgery. Vasc Health Risk Manag (2015) 0.85
Major complications of bariatric surgery: endoscopy as first-line treatment. Nat Rev Gastroenterol Hepatol (2015) 0.84
Favorable early results of gastric banding for morbid obesity: the American experience. Surg Endosc (2004) 0.84
Nonalcoholic Steatohepatitis Is Associated With Increased Mortality in Obese Patients Undergoing Bariatric Surgery. Clin Gastroenterol Hepatol (2015) 0.81
The SAGES Bariatric Surgery Outcome Initiative. Surg Endosc (2005) 0.81
Laparoscopic Roux-en-Y gastric bypass is effective and safe in over 55-year-old patients: a comparative analysis. World J Surg (2014) 0.79
Mortality rate after open Roux-in-Y gastric bypass: a 10-year follow-up. Braz J Med Biol Res (2014) 0.78
Translating weight loss into agency: Men's experiences 5 years after bariatric surgery. Int J Qual Stud Health Well-being (2015) 0.77
Multicenter prospective evaluation of a new articulating 5-mm endoscopic linear stapler. Surg Endosc (2015) 0.76
Preoperative weight gain might increase risk of gastric bypass surgery. Surg Obes Relat Dis (2010) 0.75
Are There Gender-Specific Aspects in Obesity and Metabolic Surgery? Data Analysis from the German Bariatric Surgery Registry. Viszeralmedizin (2014) 0.75
Preoperative psychological assessment of patients seeking weight-loss surgery: identifying challenges and solutions. Psychol Res Behav Manag (2015) 0.75
Does Age Influence Bariatric Surgery Outcomes? Bariatr Surg Pract Patient Care (2015) 0.75
Predictors of bariatric surgery among an interested population. Surg Obes Relat Dis (2013) 0.75
Baseline of visceral fat area and decreased body weight correlate with improved pulmonary function after Roux-en-Y gastric bypass in Chinese obese patients with BMI 28-35 kg/m² and type 2 diabetes: a 6-month follow-up. BMC Endocr Disord (2015) 0.75
Learning curve for laparoscopic Roux-en-Y gastric bypass with totally hand-sewn anastomosis: analysis of first 600 consecutive patients. Surg Endosc (2005) 0.75
The effect of age on the association between body-mass index and mortality. N Engl J Med (1998) 13.94
Body weight and mortality among women. N Engl J Med (1995) 11.04
Factors influencing wound dehiscence. Am J Surg (1992) 2.17
Excessive mortality and causes of death in morbidly obese men. JAMA (1980) 1.60
Short-term medical benefits and adverse effects of weight loss. Ann Intern Med (1993) 1.57
Risk factors in pulmonary embolism. Surg Gynecol Obstet (1976) 1.52
The association between weight loss and increased longevity. A review of the evidence. Ann Intern Med (1993) 1.48
Complications of surgery for obesity. Surg Clin North Am (2001) 1.44
The risks of surgery in obese patients. Ann Intern Med (1986) 1.38
Surgical implications of obesity. Annu Rev Med (1998) 1.21
Leaks occurring after gastric bariatric operations. Surgery (1988) 1.21
Perioperative risks and safety of surgery for severe obesity. Am J Clin Nutr (1992) 1.16
Conversion of failed or complicated vertical banded gastroplasty to gastric bypass in morbid obesity. Am J Surg (1996) 1.14
Failed gastroplasty for morbid obesity. Revised gastroplasty versus Roux-Y gastric bypass. Am J Surg (1984) 1.11
Complications following gastric bypass procedures for morbid obesity. Surgery (1979) 1.09
Gastric bypass for morbid obesity in patients more than fifty years of age. Surg Gynecol Obstet (1977) 1.06
Gastric surgery in morbid obesity. Outcome in patients aged 55 years and older. Arch Surg (1993) 0.93
Reoperative surgery for the morbidly obese. A university experience. Arch Surg (1990) 0.93
Morbid obesity. Second gastric operations for poor weight loss. Am Surg (1985) 0.91
Continuous absorbable vs interrupted nonabsorbable fascial closure. A prospective, randomized comparison. Arch Surg (1986) 0.89
Wound closure technique and acute wound complications in gastric surgery for morbid obesity: a prospective randomized trial. J Am Coll Surg (2000) 0.89
Methods for Voluntary Weight Loss and Control. Proceedings of NIH Technology Assessment Conference. Bethesda, Maryland, 30 March-1 April 1992. Ann Intern Med (1993) 0.85
Venous thromboembolism in the morbidly obese. Surg Gynecol Obstet (1978) 0.84
The conversion of a horizontal to vertical banded gastroplasty: a hazardous procedure. Gastroenterol Clin North Am (1987) 0.84
Pulmonary embolism in total hip and knee arthroplasty. Risk factors in patients on warfarin prophylaxis and analysis of the prothrombin time as an indicator of warfarin's prophylactic effect. Clin Orthop Relat Res (1992) 0.84
Postoperative venous thrombosis. Evaluation of five methods of treatment. Am J Surg (1981) 0.83
Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA (2006) 12.44
Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA (2006) 6.51
Evaluating an evidence-based bundle for preventing surgical site infection: a randomized trial. Arch Surg (2010) 4.03
Vedolizumab as induction and maintenance therapy for Crohn's disease. N Engl J Med (2013) 3.98
Vitamin D, calcium supplementation, and colorectal adenomas: results of a randomized trial. J Natl Cancer Inst (2003) 3.44
Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA (2006) 2.97
In vitro antiproliferative, apoptotic and antioxidant activities of punicalagin, ellagic acid and a total pomegranate tannin extract are enhanced in combination with other polyphenols as found in pomegranate juice. J Nutr Biochem (2005) 2.71
Surgical site infection in colorectal surgery: a review of the nonpharmacologic tools of prevention. J Am Coll Surg (2010) 2.17
Health ramifications of the obesity epidemic. Surg Clin North Am (2005) 2.10
Growth inhibitory effect of low fat diet on prostate cancer cells: results of a prospective, randomized dietary intervention trial in men with prostate cancer. J Urol (2010) 1.94
Comparison of antioxidant potency of commonly consumed polyphenol-rich beverages in the United States. J Agric Food Chem (2008) 1.92
Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer. Clin Cancer Res (2006) 1.86
Blackberry, black raspberry, blueberry, cranberry, red raspberry, and strawberry extracts inhibit growth and stimulate apoptosis of human cancer cells in vitro. J Agric Food Chem (2006) 1.84
Limitations of MTT and MTS-based assays for measurement of antiproliferative activity of green tea polyphenols. PLoS One (2010) 1.77
Ganoderma lucidum causes apoptosis in leukemia, lymphoma and multiple myeloma cells. Leuk Res (2006) 1.74
Reassessing the need for prophylactic surgery in patients with porcelain gallbladder: case series and systematic review of the literature. Arch Surg (2011) 1.71
Characterization of human fibrocytes as circulating adipocyte progenitors and the formation of human adipose tissue in SCID mice. FASEB J (2005) 1.68
Isolation and identification of strawberry phenolics with antioxidant and human cancer cell antiproliferative properties. J Agric Food Chem (2008) 1.61
Bioavailability of ellagic acid in human plasma after consumption of ellagitannins from pomegranate (Punica granatum L.) juice. Clin Chim Acta (2004) 1.60
Protective effects of plasma carotenoids on the risk of bladder cancer. J Urol (2006) 1.56
Total cranberry extract versus its phytochemical constituents: antiproliferative and synergistic effects against human tumor cell lines. J Agric Food Chem (2004) 1.52
Pomegranate juice ellagitannin metabolites are present in human plasma and some persist in urine for up to 48 hours. J Nutr (2006) 1.51
Effect of altering dietary omega-6/omega-3 fatty acid ratios on prostate cancer membrane composition, cyclooxygenase-2, and prostaglandin E2. Clin Cancer Res (2006) 1.50
Pomegranate juice, total pomegranate ellagitannins, and punicalagin suppress inflammatory cell signaling in colon cancer cells. J Agric Food Chem (2006) 1.49
Green tea inhibits vascular endothelial growth factor (VEGF) induction in human breast cancer cells. J Nutr (2002) 1.48
Antioxidant-rich spice added to hamburger meat during cooking results in reduced meat, plasma, and urine malondialdehyde concentrations. Am J Clin Nutr (2010) 1.48
PC-SPES: herbal formulation for prostate cancer. Urology (2002) 1.48
Randomized clinical trial of brewed green and black tea in men with prostate cancer prior to prostatectomy. Prostate (2014) 1.47
Bioavailability and antioxidant activity of tea flavanols after consumption of green tea, black tea, or a green tea extract supplement. Am J Clin Nutr (2004) 1.46
Low-fat high-fiber diet decreased serum and urine androgens in men. J Clin Endocrinol Metab (2005) 1.42
Pomegranate ellagitannin-derived metabolites inhibit prostate cancer growth and localize to the mouse prostate gland. J Agric Food Chem (2007) 1.41
Elevated HbA1c is an independent predictor of aggressive clinical behavior in patients with colorectal cancer: a case-control study. Dig Dis Sci (2008) 1.38
The post-adjustable gastric band abdominoplasty. Aesthet Surg J (2012) 1.38
Smac mimetics as new cancer therapeutics. Anticancer Drugs (2009) 1.32
Bowel perforation from bevacizumab for the treatment of metastatic colon cancer: incidence, etiology, and management. Curr Surg (2006) 1.29
Pomegranate extract inhibits androgen-independent prostate cancer growth through a nuclear factor-kappaB-dependent mechanism. Mol Cancer Ther (2008) 1.27
OpT2mise: a randomized controlled trial to compare insulin pump therapy with multiple daily injections in the treatment of type 2 diabetes-research design and methods. Diabetes Technol Ther (2014) 1.24
Phase II prospective randomized trial of a low-fat diet with fish oil supplementation in men undergoing radical prostatectomy. Cancer Prev Res (Phila) (2011) 1.23
Effect of isocaloric low-fat diet on human LAPC-4 prostate cancer xenografts in severe combined immunodeficient mice and the insulin-like growth factor axis. Clin Cancer Res (2003) 1.22
Catechin and caffeine content of green tea dietary supplements and correlation with antioxidant capacity. J Agric Food Chem (2006) 1.20
Curcumin exerts multiple suppressive effects on human breast carcinoma cells. Int J Cancer (2002) 1.20
Certolizumab pegol in patients with moderate to severe Crohn's disease and secondary failure to infliximab. Clin Gastroenterol Hepatol (2010) 1.19
Surgical site infections after colorectal surgery: do risk factors vary depending on the type of infection considered? Surgery (2007) 1.19
Tea polyphenols and theaflavins are present in prostate tissue of humans and mice after green and black tea consumption. J Nutr (2006) 1.18
Oridonin induces growth inhibition and apoptosis of a variety of human cancer cells. Int J Oncol (2003) 1.18
Pomegranate polyphenols down-regulate expression of androgen-synthesizing genes in human prostate cancer cells overexpressing the androgen receptor. J Nutr Biochem (2008) 1.17
Gene expression profile of metastatic colon cancer cells resistant to cisplatin-induced apoptosis. Int J Oncol (2003) 1.14
Scutellaria baicalensis, a herbal medicine: anti-proliferative and apoptotic activity against acute lymphocytic leukemia, lymphoma and myeloma cell lines. Leuk Res (2006) 1.13
Risk of prostate cancer in a randomized clinical trial of calcium supplementation. Cancer Epidemiol Biomarkers Prev (2005) 1.13
Green tea polyphenols and metabolites in prostatectomy tissue: implications for cancer prevention. Cancer Prev Res (Phila) (2010) 1.12
Catechin content of 18 teas and a green tea extract supplement correlates with the antioxidant capacity. Nutr Cancer (2003) 1.11
Analysis of the interactions of botanical extract combinations against the viability of prostate cancer cell lines. Evid Based Complement Alternat Med (2006) 1.10
The role of dietary supplements during cancer therapy. J Nutr (2003) 1.09
Ellagitannin-rich pomegranate extract inhibits angiogenesis in prostate cancer in vitro and in vivo. Int J Oncol (2008) 1.09
Nongallated compared with gallated flavan-3-ols in green and black tea are more bioavailable. J Nutr (2008) 1.08
1alpha,25-(OH)(2)-D(3) and its synthetic analogue decrease tumor load in the Apc(min) Mouse. Cancer Res (2002) 1.08
External dacryocystorhinostomy: assessing factors that influence outcome. Orbit (2010) 1.07
Chemopreventive effects of tea in prostate cancer: green tea versus black tea. Mol Nutr Food Res (2011) 1.06
Gait characteristics in people with type 2 diabetes mellitus. Eur J Appl Physiol (2004) 1.05
Green tea drinking and multigenetic index on the risk of stomach cancer in a Chinese population. Int J Cancer (2005) 1.05
Bacterial lipopolysaccharide shifts fasted plasma ghrelin to postprandial levels in rats. Neurosci Lett (2003) 1.05
Surgical bypass versus endoscopic stenting for malignant gastroduodenal obstruction: a decision analysis. Dig Dis Sci (2006) 1.04
Pistachio nuts reduce triglycerides and body weight by comparison to refined carbohydrate snack in obese subjects on a 12-week weight loss program. J Am Coll Nutr (2010) 1.04
Reduced body weight and adiposity with a high-protein diet improves functional status, lipid profiles, glycemic control, and quality of life in patients with heart failure: a feasibility study. J Cardiovasc Nurs (2009) 1.03
The combination of green tea and tamoxifen is effective against breast cancer. Carcinogenesis (2006) 1.03
Controversy: Does repetitive transcranial magnetic stimulation/ transcranial direct current stimulation show efficacy in treating tinnitus patients? Brain Stimul (2008) 1.03
Effect of isocaloric low-fat diet on prostate cancer xenograft progression to androgen independence. Cancer Res (2004) 1.03
LPS inhibits fasted plasma ghrelin levels in rats: role of IL-1 and PGs and functional implications. Am J Physiol Gastrointest Liver Physiol (2006) 1.03
Effectiveness of the MOVE! Multidisciplinary weight loss program for veterans in Los Angeles. Prev Chronic Dis (2013) 1.02
Enhanced inhibition of prostate cancer xenograft tumor growth by combining quercetin and green tea. J Nutr Biochem (2013) 1.02
Body fat and body-mass index among a multiethnic sample of college-age men and women. J Obes (2013) 1.02
Bioavailability and antioxidant effect of epigallocatechin gallate administered in purified form versus as green tea extract in healthy individuals. J Nutr Biochem (2005) 1.02
Predictors of early mortality in veteran patients with pancreatic cancer. Am J Surg (2007) 1.02
Pomegranate juice and extracts provide similar levels of plasma and urinary ellagitannin metabolites in human subjects. J Med Food (2008) 1.02
Sarcopenic obesity in the elderly and strategies for weight management. Nutr Rev (2012) 1.01
O-001 A Multicenter, Double-Blind, Placebo-Controlled Phase3 Study of Ustekinumab, a Human IL-12/23P40 mAB, in Moderate-Service Crohn's Disease Refractory to Anti-TFNα: UNITI-1. Inflamm Bowel Dis (2016) 1.01
Pomegranate extract induces apoptosis in human prostate cancer cells by modulation of the IGF-IGFBP axis. Growth Horm IGF Res (2009) 1.00
Pomegranate ellagitannin-derived compounds exhibit antiproliferative and antiaromatase activity in breast cancer cells in vitro. Cancer Prev Res (Phila) (2010) 1.00
5-SPICE: the application of an original framework for community health worker program design, quality improvement and research agenda setting. Glob Health Action (2013) 0.98
Vitamin D receptor gene polymorphisms and prognosis of breast cancer among African-American and Hispanic women. PLoS One (2013) 0.98
Fatty acid modulation of MCF-7 human breast cancer cell proliferation, apoptosis and differentiation. J Nutr Biochem (2002) 0.98
Dietary selenium intake, aldehyde dehydrogenase-2 and X-ray repair cross-complementing 1 genetic polymorphisms, and the risk of esophageal squamous cell carcinoma. Cancer (2006) 0.97
Negative pressure wound therapy with off-the-shelf components. Am J Surg (2006) 0.97
International multidimensional authenticity specification (IMAS) algorithm for detection of commercial pomegranate juice adulteration. J Agric Food Chem (2009) 0.96
Quercetin increased bioavailability and decreased methylation of green tea polyphenols in vitro and in vivo. Food Funct (2012) 0.96
Hypertriglyceridemia is a practical biomarker of metabolic syndrome in individuals with abdominal obesity. Metab Syndr Relat Disord (2012) 0.96
Prostate cancer in native Japanese and Japanese-American men: effects of dietary differences on prostatic tissue. Urology (2004) 0.95
Impairment in orthostatic tolerance during heat exposure in individuals with Type I and Type II diabetes. Med Sci Monit (2005) 0.95
Green tea extract modulates actin remodeling via Rho activity in an in vitro multistep carcinogenic model. Clin Cancer Res (2005) 0.94
Insulin, hs-CRP, leptin, and adiponectin. An analysis of their relationship to the metabolic syndrome in an obese population with an elevated waist circumference. Metab Syndr Relat Disord (2008) 0.94
Ganoderma lucidum extracts inhibit growth and induce actin polymerization in bladder cancer cells in vitro. Cancer Lett (2004) 0.94
Pancreatic schwannoma. A case report and review of the literature. JOP (2004) 0.94
Apoptosis-inducing factor and colon cancer. J Surg Res (2007) 0.93
The role of endoscopic ultrasound in the evaluation of rectal cancer. Int Semin Surg Oncol (2006) 0.93
Anticancer effects of Chinese red yeast rice versus monacolin K alone on colon cancer cells. J Nutr Biochem (2007) 0.92
Polyphenols in brewed green tea inhibit prostate tumor xenograft growth by localizing to the tumor and decreasing oxidative stress and angiogenesis. J Nutr Biochem (2012) 0.92
Practical considerations in the use of real-time continuous glucose monitoring alerts. J Diabetes Sci Technol (2010) 0.92
Atypical location of the ilioinguinal nerve during herniorrhaphy. Am J Surg (2008) 0.92
Ganoderma lucidum spore extract inhibits endothelial and breast cancer cells in vitro. Oncol Rep (2004) 0.91